In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors. Liakos A, Tsapas A, Bekiari E. Ann Intern Med 2020;173:JC70.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liakos A, Tsapas A, Bekiari E. In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors. Ann Intern Med 2020;173:JC70.
PMID: 33316195